Walleye Trading’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Walleye Trading’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,269	Closed	-$1K	–	5767
2022 Q2	$1K	Buy	+12,269	New	+$1.21K	﹤0.01%	5038
2021 Q3	–	Sell	-30,000	Closed	-$23K	–	5977
2021 Q2	$23K	Buy	+30,000	New	+$18.8K	﹤0.01%	4822

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Walleye Trading's CRXTW Position: Q3 2022 in Review

Walleye Trading sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 12,269 shares — an estimated $1K sold.

Walleye Trading first reported a position in CRXTW in Q2 2021 and held it in 2 quarters. The position peaked at $23K in Q2 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

Walleye Trading reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
Walleye Trading sold 12,269 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $1K.
Walleye Trading first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q2 2021 and held it in 2 quarters.
Walleye Trading's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $23K in Q2 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.